摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-hydroxymethyl-3-(m-tolyl)-1,2,4-oxadiazole | 1259061-56-7

中文名称
——
中文别名
——
英文名称
5-hydroxymethyl-3-(m-tolyl)-1,2,4-oxadiazole
英文别名
(3-(m-Tolyl)-1,2,4-oxadiazol-5-yl)methanol;[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methanol
5-hydroxymethyl-3-(m-tolyl)-1,2,4-oxadiazole化学式
CAS
1259061-56-7
化学式
C10H10N2O2
mdl
——
分子量
190.202
InChiKey
RADBJQJZHBVNLF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    58-59 °C
  • 沸点:
    364.7±52.0 °C(Predicted)
  • 密度:
    1.234±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    59.2
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    乙醇酸乙酯3-甲基苄胺肟potassium carbonate 作用下, 以 N,N-二甲基甲酰胺甲苯 为溶剂, 反应 8.0h, 以57%的产率得到5-hydroxymethyl-3-(m-tolyl)-1,2,4-oxadiazole
    参考文献:
    名称:
    One-Step Protection-Free Synthesis of 3-Aryl-5-hydroxyalkyl-1,2,4-oxadiazoles as Building Blocks
    摘要:
    A simple and straightforward synthesis of 3-aryl-5-hydroxyalkyl-1,2,4-oxadiazoles is described. The reaction among arylamidoximes, ethyl glycolate or ethyl lactate, and potassium carbonate in refluxing toluene afforded the desired 1,2,4-oxadiazoles in moderate to good yields. The synthesis has been accomplished in a single step, avoiding protection-deprotection protocols. Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) to view the free supplemental file.
    DOI:
    10.1080/00397911.2012.724757
点击查看最新优质反应信息

文献信息

  • [EN] CARBOSTYRIL COMPOUND<br/>[FR] DÉRIVÉ DE CARBOSTYRILE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2006035954A1
    公开(公告)日:2006-04-06
    The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R4 and R5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R1 is a hydrogen atom, etc; R2 is a hydrogen atom, etc; and R3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.
    本发明提供了一种由通式(1)表示的羧基吲哚化合物或其盐,其中A是直链键、较低的烷基烯基或较低的烷基亚烯基;X是氧原子或硫原子;R4和R5分别表示氢原子;羧基吲哚骨架的3和4位置之间的键是单键或双键;R1是氢原子,等等;R2是氢原子,等等;R3是氢原子,等等。本发明的羧基吲哚化合物或其盐诱导TFF的产生,因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和伤口等疾病。
  • Carbostyril compound
    申请人:Kuroda Takeshi
    公开号:US20070179173A1
    公开(公告)日:2007-08-02
    The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R 4 and R 5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R 1 is a hydrogen atom, etc; R 2 is a hydrogen atom, etc; and R 3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.
    本发明提供了一种由通式(1)表示的碳基噻吩化合物或其盐,其中A是直接键,较低的烷基烷基或较低的烷基亚烷基;X是氧原子或硫原子;R4和R5分别表示氢原子;碳基噻吩骨架的3和4位之间的键是单键或双键;R1是氢原子等;R2是氢原子等;R3是氢原子等。本发明的碳基噻吩化合物或其盐能够诱导TFF的产生,因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和伤口等疾病。
  • PYRIMIDODIAZEPINONE DERIVATIVE
    申请人:Otsubo Nobumasa
    公开号:US20100190775A1
    公开(公告)日:2010-07-29
    The invention provides a pyrimidodiazepinone derivative represented by the general formula (I) [wherein n represents 1 or 2, Z represents a hydrogen atom or the like, R 1 and R 2 may be the same or different, and each represents a hydrogen atom or the like, A represents a bond, (CH 2 ) m (wherein m represents an integer of 1 to 4), optionally substituted phenylene, optionally substituted pyridinediyl, or C═O, R 3 represents a hydrogen atom, optionally substituted lower alkyl, or the like, and R 4 represents a hydrogen atom or the like], or a pharmaceutically acceptable salt thereof or the like.
    该发明提供了一种由通式(I)表示的嘧啶二氮杂环酮衍生物[其中n代表1或2,Z代表氢原子或类似物,R1和R2可以相同或不同,每个代表氢原子或类似物,A代表键合,(CH2)m(其中m代表1到4的整数)、可选取代的苯基、可选取代的吡啶二基、或C═O,R3代表氢原子、可选取代的较低烷基或类似物,R4代表氢原子或类似物],或其药学上可接受的盐或类似物。
  • CARBOSTYRIL COMPOUND
    申请人:Kuroda Takeshi
    公开号:US20100261705A1
    公开(公告)日:2010-10-14
    The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R 4 and R 5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R 1 is a hydrogen atom, etc; R 2 is a hydrogen atom, etc; and R 3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.
    本发明提供了一种由通式(1)表示的羧基苯基咔唑化合物或其盐,其中A表示直接键,较低的烷基烷基或较低的烷基亚甲基烷基;X表示氧原子或硫原子;R4和R5各代表氢原子;羧基苯基咔唑骨架的3和4位置之间的键是单键或双键;R1是氢原子等;R2是氢原子等;R3是氢原子等。本发明的羧基苯基咔唑化合物或其盐可诱导TFF的产生,因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和创伤等疾病。
  • NF-kappa B Inhibitor
    申请人:Ishiyama Hironobu
    公开号:US20090326008A1
    公开(公告)日:2009-12-31
    The present invention provides an NF-κB inhibitor. The NF-κB inhibitor of the present invention contains a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R 4 and R 5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R 1 is a hydrogen atom, etc; R 2 is a hydrogen atom, etc; and R 3 is a hydrogen atom, etc.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺